Transfusion Medicine Reviews
Volume 22, Issue 2 , Pages 162-167 , April 2008

Participating in the Evolution of Transfusion Medicine From a Dispensary Into a Discipline

  • Girish N. Vyas

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Girish N. Vyas, PhD, Professor of Laboratory Medicine and Director of Transfusion Research Program, UCSF School of Medicine, Box 0100, 513 Parnassus Avenue, Suite S-561, San Francisco, CA 94143.

References 

  1. Vyas GN, Fudenberg HH. Isoimmune anti-IgA causing anaphytactoid reaction, editorial. N Engl J Med. 1969;280:1073
  2. Vyas GN, Shulman NR. Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science. 1970;170:332–333
  3. Faulk WP, Vyas GN, Phillips CA, et al. Rhinovirus: Passive hemagglutination system. Nature. 1971;231:101–104
  4. Vyas GN, Perkins HA, Yang Y, et al. Healthy blood donors with selective absence of immunoglobulin A: Prevention of anaphylactic transfusion reactions caused by antibodies to IgA. J Lab Clin Med. 1975;85:838–842
  5. Vyas GN, Levin AS, Fudenberg HH. Intra-uterine isoimmunization caused by maternal IgA crossing the placenta. Nature. 1970;225:275–276
  6. Vyas GN, Fudenberg HH. Am(1), the first genetic marker of human IgA globulin. Proc Natl Acad Sci USA. 1969;64:1211–1216
  7. van Loghem E, Wang AC, Shushter J. A new genetic marker of humanimmunoglobulins determined by an allele at the alph-2 locus. Vox Sang. 1973;24:481–488
  8. Blumberg BS. Inherited serum protein variants with emphasis on isoprecipitins and the beta lipoproteins. Vox Sang. 1965;10:366–368
  9. Stevens CE, Beasley RP. Lack of an autosomal recessive genetic influence in vertical transmission of hepatitis B antigen. Nature. 1976;260:715–716
  10. Vyas GN, Williams EW, Claus GGB, et al. Hepatitis associated Australia antigen—Protein, peptides and amino acid composition of purified antigen with its use in determining sensitivity of the hemagglutination test. J Immunol. 1972;108:1114–1118
  11. Vyas GN, Rao KR, Ibrahim AB. Hepatitis-associated Australia antigen (HBAg): A conformational antigen dependent on disulfide bonds. Science. 1972;178:1300–1301
  12. Peterson DL, Roberts IM, Vyas GN. Identical amino acid sequence of two major component polypeptides of HBsAg. Proc Natl Acad Sci U S A. 1976;74:1530–1534
  13. Tiollais P, Charnay P, Vyas GN. Biology of hepatitis B virus. Science. 1981;213:406–411
  14. Stevens CE, Toy PT, Tong MJ, et al. Perinatal hepatitis B virus transmission in the United States. J Am Med Assoc. 1985;253:1740–1745
  15. Greenman RL, Robinson WS, Vyas GN. A sensitive test for antibody against the hepatitis B core antigen (anti-HBc). Vox Sang. 1975;29:77–80
  16. Blum HE, Haase AT, Vyas GN. Molecular pathogenesis of Hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet. 1984;ii:771–775
  17. Vyas GN, Dienstag JL, Hoofnagle JH. Hepatitis and liver disease. In: New York: Grune & Stratton; 1984;
  18. Scillian JJ, McHugh TM, Busch MP, et al. Early detection of antibodies against rDNA-produced HIV proteins using a flow cytometric assay. Blood. 1989;73:2041–2048
  19. Vyas GN, Yang G, Murphy E. Transfusion-related transmissible diseases: Detection by polymerase chain reaction-amplified genes of the microbial agents. Transfus Med Rev. 1994;8:253–266
  20. Busch MP, Eble BA, Khayam-Bashi H, et al. Evaluation of contemporary screened blood donors for occult HIV-1 infection using pooled cell culture and DNA amplification techniques. N Engl J Med. 1991;325:1–5
  21. Leong MS, Babbitt W, Vyas GN. A hollow-fiber bioreactor for expanding HIV-1 in human lymphocytes used in preparing an inactivated vaccine candidate. Biologicals. 2007;35:227–233

PII: S0887-7963(07)00114-9

doi: 10.1016/j.tmrv.2007.12.005

Transfusion Medicine Reviews
Volume 22, Issue 2 , Pages 162-167 , April 2008

Article Tools

* Image Usage & Resolution